Infectious Disorders - Drug Targets
Title: Editorial [ Infectious Diseases: What is in our future? ]
Volume: 7 Issue: 1
Author(s): Robert C. Goldman
Affiliation:
Export Options
About this article
Cite this article as:
Goldman C. Robert, Editorial [ Infectious Diseases: What is in our future? ], Infectious Disorders - Drug Targets 2007; 7 (1) . https://dx.doi.org/10.2174/187152607780090676
DOI https://dx.doi.org/10.2174/187152607780090676 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
19
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mechanistic Insight of Drug Resistance with Special Focus on Iron in Estrogen Receptor Positive Breast Cancer
Current Pharmaceutical Biotechnology COX-2, Cell Proliferation and PMA in Head-and-Neck Cancer Cells
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Synthesis of New Benzimidazole and Benzothiazole Disulfide Metal Complexes as G-quadruplex Binding Ligands
Anti-Cancer Agents in Medicinal Chemistry Acetylation Control of Cancer Cell Metabolism
Current Pharmaceutical Design Molecular Mechanisms and Therapeutic Application of NSAIDs and Derived Compounds in Alzheimers Disease
Current Alzheimer Research Synthesis and Antiproliferative Evaluation of Hybrids of Indolin-2-one and Quinazoline-4(3H)-one Linked via Imine Bond
Letters in Drug Design & Discovery Exploration of the Medicinal Peptide Space
Protein & Peptide Letters Novel Genetic and Peptide-Based Strategies Targeting the Bcl-2 Family, an Update
Recent Patents on DNA & Gene Sequences Natural Killer Cells: Prospects in Cancer Immunotherapy
Current Immunology Reviews (Discontinued) Potassium Channels: Novel Emerging Biomarkers and Targets for Therapy in Cancer
Recent Patents on Anti-Cancer Drug Discovery Modulation of Cellular Response to Anticancer Treatment by Caffeine: Inhibition of Cell Cycle Checkpoints, DNA Repair and More
Current Pharmaceutical Biotechnology Therapeutic Value of Vitamin D as an Adjuvant Therapy in Neonates with Sepsis
Infectious Disorders - Drug Targets Synthesis and Antimicrobial Evaluation of Amphipathic Peptide Models
Letters in Drug Design & Discovery Nitric Oxide-Releasing Biomaterials for Biomedical Applications
Current Medicinal Chemistry Editorial [Hot Topic: Targeting G Protein and Phosphorylation Dependent Signalling Molecules for Anticancer Therapy (Guest Editor: Jeyanthy Eswaran)]
Anti-Cancer Agents in Medicinal Chemistry Interrelationship Between Periapical Lesion and Systemic Metabolic Disorders
Current Pharmaceutical Design Radionuclide Antibody-Conjugates, a Targeted Therapy Towards Cancer
Current Radiopharmaceuticals AKT and cytosolic phospholipase A<sub>2</sub>α form a positive loop in prostate cancer cells
Current Cancer Drug Targets Protein Kinase C and Prostate Carcinogenesis: Targeting the Cell Cycle and Apoptotic Mechanisms
Current Drug Targets Thermal Unfolding of Nucleoside Hydrolases from the Hyperthermophilic Archaeon Sulfolobus solfataricus: Role of Disulfide Bonds
Protein & Peptide Letters